300238 冠昊生物
已收盘 06-03 15:00:00
资讯
新帖
简况
股市必读：冠昊生物（300238）5月22日董秘有最新回复
证券之星 · 05-25
股市必读：冠昊生物（300238）5月22日董秘有最新回复
冠昊生物：截至2026年5月20日，公司股东总户数为27,025
证券之星 · 05-22
冠昊生物：截至2026年5月20日，公司股东总户数为27,025
冠昊生物(300238)4月30日股东户数2.77万户，较上期减少1.36%
证券之星 · 05-07
冠昊生物(300238)4月30日股东户数2.77万户，较上期减少1.36%
每周股票复盘：冠昊生物（300238）股东户数减少395户
证券之星 · 05-03
每周股票复盘：冠昊生物（300238）股东户数减少395户
冠昊生物(300238)4月20日股东户数2.81万户，较上期减少1.39%
证券之星 · 04-29
冠昊生物(300238)4月20日股东户数2.81万户，较上期减少1.39%
图解冠昊生物一季报：第一季度单季净利润同比下降31.64%
证券之星 · 04-29
图解冠昊生物一季报：第一季度单季净利润同比下降31.64%
股市必读：冠昊生物(300238)股东户数2.81万户，较上期减少1.39%
证券之星 · 04-27
股市必读：冠昊生物(300238)股东户数2.81万户，较上期减少1.39%
冠昊生物：截至2026年4月20日，公司股东总户数为28,116
证券之星 · 04-24
冠昊生物：截至2026年4月20日，公司股东总户数为28,116
冠昊生物：本次向特定对象发行股票目前尚未定价
证券之星 · 04-20
冠昊生物：本次向特定对象发行股票目前尚未定价
冠昊生物（300238）披露2025年年度股东会决议公告，4月16日股价下跌0.97%
证券之星 · 04-16
冠昊生物（300238）披露2025年年度股东会决议公告，4月16日股价下跌0.97%
股市必读：冠昊生物（300238）4月10日披露最新机构调研信息
证券之星 · 04-13
股市必读：冠昊生物（300238）4月10日披露最新机构调研信息
冠昊生物(300238)3月31日股东户数2.85万户，较上期减少3.14%
证券之星 · 04-06
冠昊生物(300238)3月31日股东户数2.85万户，较上期减少3.14%
冠昊生物（300238）2025年年报简析：增收不增利，公司应收账款体量较大
证券之星 · 03-27
冠昊生物（300238）2025年年报简析：增收不增利，公司应收账款体量较大
冠昊生物（300238）披露2025年年度报告，3月25日股价下跌1.94%
证券之星 · 03-25
冠昊生物（300238）披露2025年年度报告，3月25日股价下跌1.94%
冠昊生物：2026年4月15日召开2025年年度股东会
证券日报 · 03-25
冠昊生物：2026年4月15日召开2025年年度股东会
冠昊生物(300238.SZ)发布2025年度业绩，归母净利润2434.6万元，下降11.20%
智通财经 · 03-25
冠昊生物(300238.SZ)发布2025年度业绩，归母净利润2434.6万元，下降11.20%
冠昊生物（300238）披露关于补缴税款的公告，3月13日股价上涨0.69%
证券之星 · 03-13
冠昊生物（300238）披露关于补缴税款的公告，3月13日股价上涨0.69%
冠昊生物（300238）披露独立董事任期届满公告，3月11日股价上涨0.13%
证券之星 · 03-11
冠昊生物（300238）披露独立董事任期届满公告，3月11日股价上涨0.13%
股市必读：冠昊生物（300238）3月2日董秘有最新回复
证券之星 · 03-03
股市必读：冠昊生物（300238）3月2日董秘有最新回复
冠昊生物：截止2026年2月27日，公司股东总户数为29,506
证券之星 · 03-02
冠昊生物：截止2026年2月27日，公司股东总户数为29,506
暂无数据
公司概况
公司名称：
冠昊生物科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2011-07-06
主营业务：
冠昊生物科技股份有限公司的主营业务是材料、药业、细胞三大业务。公司的主要产品是生物型硬脑（脊）膜补片、B型硬脑（脊）膜补片、无菌生物护创膜、艾瑞欧TM乳房补片、胸普外科修补膜片、安润可降解泪小管栓、欣比克本维莫德乳膏、细胞技术服务。报告期内，冠昊生物荣获国家专精特新“小巨人”称号。
发行价格：
18.20
{"stockData":{"symbol":"300238","market":"SZ","secType":"STK","nameCN":"冠昊生物","latestPrice":11.55,"timestamp":1780470198000,"preClose":11.75,"halted":0,"volume":2932200,"delay":0,"changeRate":-0.017,"floatShares":265000000,"shares":265000000,"eps":0.0741,"marketStatus":"已收盘","change":-0.2,"latestTime":"06-03 15:00:00","open":11.77,"high":11.78,"low":11.5,"amount":34000500,"amplitude":0.0238,"askPrice":11.55,"askSize":7,"bidPrice":11.54,"bidSize":10,"shortable":0,"etf":0,"ttmEps":0.0741,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780536600000},"marketStatusCode":5,"adr":0,"adjPreClose":11.75,"symbolType":"stock","openAndCloseTimeList":[[1780450200000,1780457400000],[1780462800000,1780470000000]],"highLimit":12.93,"lowLimit":10.58,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":265155701,"isCdr":false,"pbRate":5.37,"roa":"--","peRate":155.870445,"roe":"1.77%","epsLYR":0.09,"committee":-0.610063,"marketValue":3063000000,"turnoverRate":0.0111,"status":1,"floatMarketCap":3062000000},"requestUrl":"/m/hq/s/300238/tweets","defaultTab":"tweets","newsList":[{"id":"2638230769","title":"股市必读：冠昊生物（300238）5月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2638230769","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638230769?lang=zh_cn&edition=full","pubTime":"2026-05-25 03:59","pubTimestamp":1779652748,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，冠昊生物报收于12.89元，上涨1.58%，换手率1.36%，成交量3.61万手，成交额4619.9万元。董秘最新回复投资者： 请问截至2026年5月15日，公司股东数是多少？截至2026年5月20日，公司股东总户数为27,025。感谢您的关注与支持！当日关注点来自交易信息汇总：5月22日主力资金净流出208.79万元，散户资金净流入124.87万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500001647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","300238","BK0086","BK0046","BK0251","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637946803","title":"冠昊生物：截至2026年5月20日，公司股东总户数为27,025","url":"https://stock-news.laohu8.com/highlight/detail?id=2637946803","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637946803?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:24","pubTimestamp":1779438251,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)05月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年5月15日，公司股东数是多少？冠昊生物回复：尊敬的投资者您好！截至2026年5月20日，公司股东总户数为27,025。感谢您的关注与支持！以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200029547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0077","BK0046","BK0086","BK0042","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633117591","title":"冠昊生物(300238)4月30日股东户数2.77万户，较上期减少1.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633117591","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633117591?lang=zh_cn&edition=full","pubTime":"2026-05-07 17:33","pubTimestamp":1778146437,"startTime":"0","endTime":"0","summary":"证券之星消息，近日冠昊生物披露，截至2026年4月30日公司股东户数为2.77万户，较4月20日减少382.0户，减幅为1.36%。在医疗器械行业个股中，冠昊生物股东户数高于行业平均水平，截至4月30日，医疗器械行业平均股东户数为2.21万户。从股价来看，2026年4月20日至2026年4月30日，冠昊生物区间跌幅为7.37%，在此期间股东户数减少382.0户，减幅为1.36%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700028982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0086","BK0042","BK0077","BK0046","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632775546","title":"每周股票复盘：冠昊生物（300238）股东户数减少395户","url":"https://stock-news.laohu8.com/highlight/detail?id=2632775546","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632775546?lang=zh_cn&edition=full","pubTime":"2026-05-03 05:28","pubTimestamp":1777757296,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，冠昊生物报收于14.21元，较上周的14.45元下跌1.66%。本周，冠昊生物4月28日盘中最高价报14.71元。冠昊生物当前最新总市值37.68亿元，在医疗器械板块市值排名93/129，在两市A股市值排名4141/5200。业绩披露要点：2026年一季度，冠昊生物归母净利润1016.23万元，同比下降31.64%。股本股东变化股东户数变动截至2026年4月20日，冠昊生物股东户数为2.81万户，较3月31日减少395.0户，减幅为1.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0042","BK0046","BK0251","BK0077","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631066599","title":"冠昊生物(300238)4月20日股东户数2.81万户，较上期减少1.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631066599","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631066599?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:00","pubTimestamp":1777456812,"startTime":"0","endTime":"0","summary":"证券之星消息，近日冠昊生物披露，截至2026年4月20日公司股东户数为2.81万户，较3月31日减少395.0户，减幅为1.39%。在医疗器械行业个股中，冠昊生物股东户数高于行业平均水平，截至4月20日，医疗器械行业平均股东户数为2.2万户。从股价来看，2026年3月31日至2026年4月20日，冠昊生物区间涨幅为5.94%，在此期间股东户数减少395.0户，减幅为1.39%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900056749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0046","BK0251","BK0042","300238","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631532504","title":"图解冠昊生物一季报：第一季度单季净利润同比下降31.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631532504","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631532504?lang=zh_cn&edition=full","pubTime":"2026-04-29 06:22","pubTimestamp":1777414950,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物2026年一季报显示，一季度公司主营收入9344.4万元，同比下降1.43%；归母净利润1016.23万元，同比下降31.64%；扣非净利润924.27万元，同比下降33.34%；负债率37.13%，投资收益-15.3万元，财务费用69.35万元，毛利率76.64%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900015115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630337293","title":"股市必读：冠昊生物(300238)股东户数2.81万户，较上期减少1.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630337293","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630337293?lang=zh_cn&edition=full","pubTime":"2026-04-27 08:48","pubTimestamp":1777250891,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，冠昊生物报收于14.45元，下跌0.69%，换手率1.44%，成交量3.82万手，成交额5488.07万元。来自股本股东变化：截至4月20日股东户数环比下降1.39%，户均持股数量升至9431.0股。股本股东变化股东户数变动近日冠昊生物披露，截至2026年4月20日公司股东户数为2.81万户，较3月31日减少395.0户，减幅为1.39%。户均持股数量由上期的9300.0股增加至9431.0股，户均持股市值为14.47万元。董秘最新回复投资者： 请问截至2026年4月23日，公司股东数是多少？","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700007739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0086","BK0046","BK0251","BK0042","300238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629815704","title":"冠昊生物：截至2026年4月20日，公司股东总户数为28,116","url":"https://stock-news.laohu8.com/highlight/detail?id=2629815704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629815704?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:12","pubTimestamp":1777018333,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)04月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年4月23日，公司股东数是多少？冠昊生物回复：尊敬的投资者您好！截至2026年4月20日，公司股东总户数为28,116。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400048549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0086","300238","BK0251","BK0046","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628074345","title":"冠昊生物：本次向特定对象发行股票目前尚未定价","url":"https://stock-news.laohu8.com/highlight/detail?id=2628074345","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628074345?lang=zh_cn&edition=full","pubTime":"2026-04-20 16:45","pubTimestamp":1776674712,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)04月20日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，咨询一下，公司4月15日股东会已通过定增议案，请问什么时候能确定定增价格。冠昊生物回复：尊敬的投资者您好！本次向特定对象发行股票目前尚未定价，最终发行价格将按照法律法规、规范性文件的相关规定及发行对象申购报价的情况确定。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000022123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0042","BK0086","BK0251","BK0046","300238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627296592","title":"冠昊生物（300238）披露2025年年度股东会决议公告，4月16日股价下跌0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627296592","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627296592?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:38","pubTimestamp":1776332329,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘，冠昊生物报收于15.3元，较前一交易日下跌0.97%，最新总市值为40.57亿元。该股当日开盘15.41元，最高15.42元，最低15.16元，成交额达7020.42万元，换手率为1.74%。冠昊生物于2026年4月16日披露《2025年年度股东会决议公告》。所有议案均获表决通过，无否决议案。出席会议股东共193人，代表有表决权股份总数的29.9234%。北京市天元律师事务所对本次会议出具法律意见书，认为会议召集、召开程序及表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600032094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0042","BK0046","BK0086","BK0251","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627030651","title":"股市必读：冠昊生物（300238）4月10日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2627030651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627030651?lang=zh_cn&edition=full","pubTime":"2026-04-13 00:58","pubTimestamp":1776013090,"startTime":"0","endTime":"0","summary":"截至2026年4月10日收盘，冠昊生物报收于15.36元，上涨1.05%，换手率2.68%，成交量7.1万手，成交额1.1亿元。当日关注点来自交易信息汇总：4月10日主力与游资资金均呈净流出状态，散户资金净流入近900万元。公司股票价格受二级市场等多方面因素影响，公司始终致力做好生产经营管理工作，推动公司健康可持续发展，重视保护投资者尤其是中小投资者的利益。如有相关安排，公司将严格按照法律法规履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041300000457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0086","300238","BK0251","BK0046","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625782506","title":"冠昊生物(300238)3月31日股东户数2.85万户，较上期减少3.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625782506","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625782506?lang=zh_cn&edition=full","pubTime":"2026-04-06 17:02","pubTimestamp":1775466164,"startTime":"0","endTime":"0","summary":"证券之星消息，近日冠昊生物披露，截至2026年3月31日公司股东户数为2.85万户，较3月10日减少924.0户，减幅为3.14%。在医疗器械行业个股中，冠昊生物股东户数高于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.19万户。从股价来看，2026年3月10日至2026年3月31日，冠昊生物区间跌幅为9.44%，在此期间股东户数减少924.0户，减幅为3.14%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040600002045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","300238","BK0086","BK0251","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622489475","title":"冠昊生物（300238）2025年年报简析：增收不增利，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2622489475","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622489475?lang=zh_cn&edition=full","pubTime":"2026-03-27 06:09","pubTimestamp":1774562973,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期冠昊生物发布2025年年报。截至本报告期末，公司营业总收入3.88亿元，同比上升2.72%，归母净利润2434.6万元，同比下降11.2%。本报告期冠昊生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达215.45%。经营活动产生的现金流量净额变动幅度为44.23%,原因:本报告期销售回款同比增加。筹资活动产生的现金流量净额变动幅度为-51.79%,原因:本报告期天昊中山医药科技项目取得项目贷款同比减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700008443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0046","BK0077","BK0042","BK0251","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622072640","title":"冠昊生物（300238）披露2025年年度报告，3月25日股价下跌1.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622072640","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622072640?lang=zh_cn&edition=full","pubTime":"2026-03-25 22:24","pubTimestamp":1774448693,"startTime":"0","endTime":"0","summary":"截至2026年3月25日收盘，冠昊生物报收于15.13元，较前一交易日下跌1.94%，最新总市值为40.12亿元。近日，冠昊生物科技股份有限公司披露《2025年年度报告》。公告显示，截至2025年末，公司总资产为806,532,412.19元，较上年末增长6.91%；归属于上市公司股东的净资产为570,067,516.98元，同比增长5.11%。2025年营业收入为387,749,767.90元，同比增长2.72%；归属于上市公司股东的净利润为24,346,028.28元，同比下降11.20%；扣除非经常性损益后的净利润为26,311,919.29元，同比增长33.47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500044146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0077","BK0042","300238","BK0251","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622351074","title":"冠昊生物：2026年4月15日召开2025年年度股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2622351074","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622351074?lang=zh_cn&edition=full","pubTime":"2026-03-25 21:23","pubTimestamp":1774444980,"startTime":"0","endTime":"0","summary":"证券日报网讯 3月25日，冠昊生物发布公告称，公司将于2026年4月15日召开2025年年度股东会。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-25/doc-inhsfmmt9592241.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-25/doc-inhsfmmt9592241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0086","BK0077","BK0046","300238","BK0042","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622027945","title":"冠昊生物(300238.SZ)发布2025年度业绩，归母净利润2434.6万元，下降11.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622027945","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622027945?lang=zh_cn&edition=full","pubTime":"2026-03-25 18:53","pubTimestamp":1774435998,"startTime":"0","endTime":"0","summary":"智通财经APP讯，冠昊生物(300238.SZ)发布2025年年度报告，该公司营业收入为3.88亿元，同比增长2.72%。归属于上市公司股东的净利润为2434.6万元，同比减少11.20%。归属于上市公司股东的扣除非经常性损益的净利润为2631.19万元，同比增长33.47%。基本每股收益为0.09元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"冠昊生物(300238.SZ)发布2025年度业绩，归母净利润2434.6万元，下降11.20%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619111527","title":"冠昊生物（300238）披露关于补缴税款的公告，3月13日股价上涨0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619111527","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619111527?lang=zh_cn&edition=full","pubTime":"2026-03-13 22:53","pubTimestamp":1773413591,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，冠昊生物报收于16.1元，较前一交易日上涨0.69%，最新总市值为42.69亿元。近日，冠昊生物科技股份有限公司发布《关于补缴税款的公告》。公告显示，公司根据税务部门要求，对涉税事项开展自查，需补缴税款及滞纳金合计1,729.81万元，其中税款1,491.44万元，滞纳金238.37万元，金额为初步测算，最终以税务局系统为准。公司将在10个工作日内完成缴纳，本次补缴不涉及行政处罚。本次补缴不影响公司正常经营。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300042039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0042","300238","BK0086","BK0046","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618259799","title":"冠昊生物（300238）披露独立董事任期届满公告，3月11日股价上涨0.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618259799","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618259799?lang=zh_cn&edition=full","pubTime":"2026-03-11 22:30","pubTimestamp":1773239442,"startTime":"0","endTime":"0","summary":"截至2026年3月11日收盘，冠昊生物报收于16.01元，较前一交易日上涨0.13%，最新总市值为42.45亿元。公告显示，公司独立董事韩俊梅女士自2020年3月13日起任职，连续任职已达六年，任期届满后不再担任公司第六届董事会独立董事及董事会各专门委员会职务。截至公告日，韩俊梅女士未持有公司股份，无未履行承诺事项。因其离任将导致独立董事人数低于法定比例，她需继续履职至新任独立董事选举产生。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100039591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","300238","BK0086","BK0251","BK0046","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616357523","title":"股市必读：冠昊生物（300238）3月2日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2616357523","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616357523?lang=zh_cn&edition=full","pubTime":"2026-03-03 01:34","pubTimestamp":1772472851,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，冠昊生物报收于15.28元，下跌4.8%，换手率2.92%，成交量7.73万手，成交额1.19亿元。董秘最新回复投资者： 您好，截止到2月底公司的股东人数是多少？截止2026年2月27日，公司股东总户数为29,506。感谢您的关注与支持！当日关注点来自交易信息汇总：主力资金3月2日净流出1669.35万元，市场呈现主力离场、中小资金接盘态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300000871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0251","BK0042","BK0086","BK0077","300238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616384955","title":"冠昊生物：截止2026年2月27日，公司股东总户数为29,506","url":"https://stock-news.laohu8.com/highlight/detail?id=2616384955","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616384955?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:45","pubTimestamp":1772441112,"startTime":"0","endTime":"0","summary":"证券之星消息，冠昊生物(300238)03月02日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问，贵公司截止2月28日股东人数是多少？谢谢！冠昊生物回复：尊敬的投资者您好！截止2026年2月27日，公司股东总户数为29,506。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200023187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0042","BK0086","300238","BK0046","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780496602512,"stockEarnings":[{"period":"1week","weight":-0.0447},{"period":"1month","weight":-0.1731},{"period":"3month","weight":-0.198},{"period":"6month","weight":-0.1963},{"period":"1year","weight":-0.233},{"period":"ytd","weight":-0.1516}],"compareEarnings":[{"period":"1week","weight":-0.017},{"period":"1month","weight":-0.009},{"period":"3month","weight":-0.0018},{"period":"6month","weight":0.0514},{"period":"1year","weight":0.2174},{"period":"ytd","weight":0.0268}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"冠昊生物科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"27025人(较上一季度减少2.56%)","perCapita":"9810股","listingDate":"2011-07-06","address":"广东省广州市黄埔区玉岩路12号","registeredCapital":"26515万元","survey":" 冠昊生物科技股份有限公司的主营业务是材料、药业、细胞三大业务。公司的主要产品是生物型硬脑（脊）膜补片、B型硬脑（脊）膜补片、无菌生物护创膜、艾瑞欧TM乳房补片、胸普外科修补膜片、安润可降解泪小管栓、欣比克本维莫德乳膏、细胞技术服务。报告期内，冠昊生物荣获国家专精特新“小巨人”称号。","listedPrice":18.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"冠昊生物(300238)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供冠昊生物(300238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"冠昊生物,300238,冠昊生物股票,冠昊生物股票老虎,冠昊生物股票老虎国际,冠昊生物行情,冠昊生物股票行情,冠昊生物股价,冠昊生物股市,冠昊生物股票价格,冠昊生物股票交易,冠昊生物股票购买,冠昊生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"冠昊生物(300238)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供冠昊生物(300238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}